ATCC Wins $545 Million Contract to Respond to Emerging Infectious Disease Threats

Headshot of Joseph Leonelli, SVP of ATCC Federal Solutions
Published on :

As the world continues to grapple with the ongoing COVID-19 pandemic and the emergence of the new omicron variant, Virginia’s ATCC secured a seven-year Delivery/Indefinite Quantity (IDIQ) contract from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, valued at up to $545 million.